Winway Health Desk
Here’s how Penn Medicine is addressing innovation
As healthcare organizations strive to keep up with changes in the medical world, one health system in Philadelphia is taking its own approach to...
Type 1 diabetes rates investigated among children of mothers with gestational...
Clinicians have been urged to ensure children of mothers with gestational diabetes receive early screening for type 1 diabetes. The warning comes...
Feds oppose white-coat kickbacks suit out of ‘animus’ against whistleblowers: judge
A group of whistleblowers made waves in pharma by suing numerous drugmakers, claiming the companies used nurse educators and other services as kickbacks to boost...
San Francisco-based clinical data startup Verana Health expands into neurology
Clinical data startup Verana Health has branched out from its initial focus on ophthalmology through a partnership with the American Academy of Neurology (AAN) to...
Educating teenagers about junk food reduces consumption, study suggests
Educating teenagers about junk food and how adverts are used to influence them reduces their purchasing habits by 31%, US researchers have...
Big spending from AbbVie, Pfizer pushes pharma’s 2018 ad spend to...
Pharmaceutical ad spending continued its upward climb last year. Spending topped $6.46 billion in 2018, according to Kantar Media, for an increase of 4.8%...
Check out the speaker lineup for MedCity’s healthcare investment conference in...
MedCity INVEST is coming up next month. We’ve lined up a fantastic group of speakers for the two day conference in Chicago at the Ritz Carlton April...
China’s GenScript starts on plasmid, virus making facility
Chinese CDMO GenScript Biotech already has a deal to produce a CAR-T drug being developed by its Legend Biotech unit and Janssen. But the...
Direct-to-consumer lab testing startup EverlyWell raises $50 million
Consumer diagnostics company EverlyWell has raised a $50 million financing round as it looks to build out its digital platform and expand its retail...
Novartis’ speedy brolucizumab review tees up battle with Eylea, Lucentis
Look out, Roche and Regeneron—Novartis eye candidate brolucizumab is on its way.
Monday, the FDA said it had granted the wet age-related macular degeneration (AMD)...
